Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 11, 2025

CNS-penetrant NLRP3 inhibitor achieves durable weight loss and reverses hypothalamic inflammation in diet-induced obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJing GuoMudanjiang Normal UniversityTBTomás P. BachorUniversity of California, San FranciscoRTRyan TakahashiTetra Therapeutics (United States)

Discussion

Loading...

Member takes

Implication

Investigating TN-783 reveals durable weight loss and central action against hypothalamic inflammation in diet-induced obesity.

Key Points

  • Sustained weight loss was achieved in diet-induced obese mice with ongoing use of TN-783, highlighting its central action.
  • TN-783 uniquely suppressed hypothalamic neuroinflammation and enhanced weight loss effects alongside semaglutide treatment.
  • Activation of the nlrp3 inflammasome in obesity indicates a crucial link between metabolic dysregulation and inflammation.
  • Ongoing interference is needed with TN-783 to maintain weight management benefits, suggesting a reversible therapeutic approach.

Cite This Study

Guo et al. (2025) studied this question.

synapsesocial.com/papers/68e9b1b5ba7d64b6fc131f55https://doi.org/10.1101/2025.10.06.680810
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity2023 · 45 citations
  2. 2Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial2024 · 348 citations
  3. 3Reciprocal activity of AgRP and POMC neurons governs coordinated control of feeding and metabolism2024 · 89 citations
  4. 4Consumption of a Fat-Rich Diet Activates a Proinflammatory Response and Induces Insulin Resistance in the Hypothalamus2005 · 1,192 citations
  5. 5Autoimmune disease preceding amyotrophic lateral sclerosis2013 · 188 citations